In AD patients, hyperactivation of GSK-3β, the NMDA receptor (NMDA), and BACE-1 have been shown to be involved in the development and deposition of one or more of the main pathological hallmarks of AD, and specifically, the formation of amyloid plaques and neurofibrillary tangles. Here, GSK3B is linked to Alzheimer disease.